Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations

Na minha lista:

Detalhes bibliográficos
Publicado no:	Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 28742-28754
Autor principal:	Khan, Mohd Shahnawaz
Outros Autores:	Shamsi, Anas, Shahwan, Moyad, Dinislam, Khuzin, Yadav, Dharmendra Kumar
Publicado em:	Nature Publishing Group
Assuntos:	Food & Drug Administration > FDA Cancer PD-L1 protein Binders Bioinformatics Therapeutic targets Binding sites Biological products Drug development Computer applications Molecular dynamics Efficiency Proteins Simulation Principal components analysis FDA approval Immune checkpoint Antineoplastic drugs Pharmacokinetics Ligands Immunosuppressive agents Cancer therapies Environmental
Acesso em linha:	Citation/Abstract Full Text Full Text - PDF
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Seja o primeiro a partilhar um comentário!